Ozempic ‘microdosing’ is new weight-loss trend

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...
Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...
How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...